Mgp Ingredients Inc (MGPI) · Oct 28, 2026 · Earnings
In line — GAAP EPS $0.32 vs ~$0.324 consensus; sales $117.9M vs ~$119.7M
MGP Ingredients earnings were roughly in line on EPS but missed revenue as Distilling Solutions deteriorated and leverage climbed.
MGP is in the middle of a business reset: it is trying to shift the mix toward branded spirits and specialty ingredients while absorbing a prolonged oversupply problem in bulk whiskey and operating-cost pressure in ingredients. Its stated strategy emphasizes branded growth, specialty proteins and fibers, and better use of its distilling platform, but the underlying distilling market remains structurally difficult.
The quarter was broadly in line on earnings, but weaker on sales. GAAP EPS of $0.32 was essentially at the published consensus of roughly $0.324, while revenue of $117.9 million came in below the roughly $119.7 million expectation. That makes this less a clean earnings beat than a mixed print: cost control and the earnings mix held up, but demand and volume were softer than expected.
| Metric | Q3 2026 | Q3 2025 | Versus expectation / change |
|---|---|---|---|
| Sales | $117.9M | $130.9M | ~$119.7M consensus; down 10% |
| GAAP EPS | $0.32 | $0.71 | ~$0.324 consensus |
| Adjusted EPS | $0.39 | $0.85 | Down 54% |
| Adjusted EBITDA | $21.5M | $32.3M | Down 33% |
| Gross margin | 34.3% | 37.8% | Down 350 bps |
| Net debt leverage | 3.6x | 1.8x | Higher year over year |
Distilling Solutions is still the central problem. Sales fell 29% as brown-goods revenue dropped 47%, taking segment operating income down 34%; management explicitly said the business continued to navigate an “oversupplied market.” 〔0〕 This was partly expected, but the magnitude remains the main drag on the company’s earnings power.
The growth areas are growing, but not profitably enough yet. Ingredient Solutions sales increased 5%, led by specialty proteins and biofuel byproducts, but gross margin fell to 6.0% from 10.3% because of higher waste-starch costs and operating income declined 37%. Branded Spirits was more resilient: sales declined 4%, but operating income rose 3%, helped by growth in Penelope Bourbon and mid-priced brands. 〔1〕
Cash generation and leverage remain the constraint on the turnaround. The company reported quarterly operating cash flow of $32 million, but year-to-date operating cash flow was negative $8.9 million after the $48.7 million Penelope earnout payment; excluding that payment, year-to-date operating cash flow was positive $39.8 million. Debt reduction is progress, but leverage at 3.6x is materially above last year’s 1.8x and leaves less room for operational setbacks.
Reaffirmed guidance prevents the quarter from becoming a reset. Management reaffirmed its full-year outlook after saying adjusted EBITDA, adjusted EPS and ending leverage were ahead of internal expectations. Prior guidance called for $480 million-$500 million of sales, $90 million-$98 million of adjusted EBITDA and $1.50-$1.80 of adjusted EPS. The unchanged outlook says management still views the weakness as manageable, but it does not erase the sharp year-to-date deterioration in operating income or the pressure in Distilling Solutions.
Bottom line: This was an in-line earnings quarter with a revenue miss and no guidance cut, not a clean improvement in the turnaround. Branded Spirits is holding up, but the business still depends on a recovery in bulk distilling and better ingredient margins while leverage remains elevated.
Sempreon/CASK rebrand takes effect November 2
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!